HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticonvulsant action of metabotropic glutamate receptor agonists in kindled amygdala of rats.

Abstract
1S,3R-1-Aminocyclopentane-1,3-dicarboxylate (1S,3R-ACPD) and L-2-amino-4-phosphonobutyrate (L-AP4) are selective agonists of metabotropic glutamate receptors (mGluRs). 1S,3R-ACPD (200 nmol) injected into the amygdala (AM) of non-kindled rats produced immediate and transient seizures, characterized by immobility, searching, and wet-dog shakes. However, this ictal response was not observed in AM-kindled rats. Intra-AM injection of 1S,3R-ACPD (40 or 200 nmol) or L-AP4 (200 nmol) resulted in a delayed and marked suppression of kindled seizures, 3 days after 40 nmol of 1S,3R-ACPD, 1 day after 200 nmol of 1S,3R-ACPD, and from 1 to 3 days after 200 nmol of L-AP4. These and the previous findings suggest that: (1) the excitatory action of 1S,3R-ACPD in the AM, which may be mediated by the postsynaptic mGluRs, is reduced after completion of kindling; (2) 1S,3R-ACPD and L-AP4 exert anti-convulsant action in the AM, presumably by activating the presynaptic as well as postsynaptic mGluRs.
AuthorsK Suzuki, N Mori, H Kittaka, Y Iwata, Y Yamada, K Osonoe, S Niwa
JournalNeuroscience letters (Neurosci Lett) Vol. 204 Issue 1-2 Pg. 41-4 (Feb 02 1996) ISSN: 0304-3940 [Print] Ireland
PMID8929973 (Publication Type: Journal Article)
Chemical References
  • Aminobutyrates
  • Anticonvulsants
  • Excitatory Amino Acid Agonists
  • Receptors, Metabotropic Glutamate
  • Cycloleucine
  • 1-amino-1,3-dicarboxycyclopentane
  • 2-amino-4-phosphonobutyric acid
Topics
  • Aminobutyrates (pharmacology)
  • Amygdala (drug effects, physiology)
  • Animals
  • Anticonvulsants (pharmacology)
  • Cycloleucine (analogs & derivatives, pharmacology)
  • Electroencephalography (drug effects)
  • Excitatory Amino Acid Agonists (pharmacology)
  • Injections
  • Kindling, Neurologic (drug effects)
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Metabotropic Glutamate (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: